◆ 会议时间:2023年9月9日至12日
◆ 会议地点:意大利 维罗纳
◆ 会议简介:
2023年第34届国际外科、消化道和肿瘤科医师协会(IASGO)世界大会将于2023年9月9日至12日在意大利维罗纳举行。IASGO世界大会将为来自世界各地的外科医生、胃肠病学家和肿瘤学家提供一个分享最新知识和专业知识,交流在外科内窥镜检查、胃肠道外科、HPB外科和肿瘤学领域所遇到的新方法和挑战的绝佳机会。
国际外科、消化道和肿瘤科医师协会(IASGO)是国际消化外科领域最具权威的学术组织之一,其前身是1988年由希腊的N.Lygidakis和美国的Stazle(国际“肝脏移植之父”)等倡导并创立的国际外科俱乐部(International Surgical Club),现在70多个国家设有分支机构。IASGO的宗旨是聚集不同领域的医学专家、通过一个结构良好、组织完善的持续医学教育系统,促进医学知识和专业技能的全球化,使每位医学专家都能获得同等的继续医学教育机会及最先进的医学知识及技能,并造福人类。
IASGO每年举办数十次教育活动,将当前最有效和最安全的胃肠道肿瘤治疗方法的信息提供给全世界的医生。IASGO官方世界大会是IASGO主办的规模最大、最具代表性和最引人注目的国际盛会,每年在其成员国举行。IASGO官方世界大会是医学界备受瞩目的事件之一,将汇集来自全球80多个国家的数千专业人士,包括肿瘤学、外科、复苏、胃肠病学和移植医学领域宣的顶尖专家;领域医学。IASGO世界大会议题广泛,包括外科、肿瘤学、放射治疗和器官移植等方面的所有现代问题;特别是将对前一年的研究成果进行讨论,并对其未来的前景和功效进行评估。根据大会的结果,制定了各种疾病的诊断和治疗的国际建议。IASGO世界大会不仅具有很高的科学性,而且对医学界也具有现实意义。
IASGO除了组织年度世界大会,还组织有着28年历史的年度高级研究生培训课程。这个项目的主要特点是跨国界和多学科结构,这些课程总是与各国家大学或政府当局密切合作,旨在给参与者提供在外科、放射、肿瘤内科、内窥镜和介入放射学等领域的最新进展。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
IASGO 2023 - 34th World Congress of the International Associations of Surgeons, Gastroenterologists, and Oncologists (IASGO)
Dates: 9–12 September 2023
Venue: Verona, Italy
摘要征集:
Important Dates
Call for abstracts: opening
16 January 2023
Abstract submission deadline
15 June 2023
Notification of Acceptance
30 June 2023
Last deadline for authors to register
7 July 2023
Abstract Submission Guidelines
The abstract must be written and presented in English.
Abstracts must contain original data and meet international ethical standards.
The abstract title and the author(s) or names of institutions are not to be included in the abstract text.
Instructions for Preparing Abstracts
Please read the following instructions carefully before preparing your abstract.
To ensure that the Abstract Submission System will work properly, the pop-up blocker of your internet browser needs to be turned off, and cookies should be enabled.
Abstract authors should keep data separate to create several abstracts from one data set. If splitting is deemed to have occurred, the abstracts will be rejected.
1. The Title of the Abstract:
The title of the abstract must be less than 20 characters.
Identifying information such as author or institution names should not be included in the title.
2. Abstract Format
• A maximum of 300 words are allowed for each paragraph.
• Images and tables may NOT be included in the abstract.
The abstract must be split into the following sections:
-
Background and Purpose: a statement of the hypothesis or research question
-
Material and Methods: an explanation of the study design and experimental methods used
-
Results: a concise summary of the significant findings of the experiment or study. Sufficient data must be provided to permit evaluation by the reviewers and public reading the abstracts. Statements such as “the data will be discussed” are not acceptable.
-
Conclusion(s): summary of the overall findings and the importance of the study.
-
Keyword(s): a tool to help indexers and search engines find relevant papers
The maximum number of authors is 15.
Abstracts should not contain proprietary or confidential information.
All signing authors and investigators are responsible for all studies concerning national legislation, international legislation and ethical guidelines regarding human and animal studies.
Failure to adhere to these rules will result in the automatic rejection of the abstract.
Video Submission Rules
Please submit the textual abstract along with your video, following the Abstract Format instructions above.
Video must be submitted online through a link where the author has previously submitted the video. Any type of link can be submitted. Please be aware that the link must be open to allow the evaluation of the abstracts.
Videos must include verbal narration. Narration must use generic terms, and no use of commercial/proprietary names is allowed. Videos must be at most 7 minutes, together with video slides in length.
Videos will be rated based on the surgical procedure’s relevancy, the video’s production quality, value as a teaching aid for inclusion in the ACS Video Library, and adherence to the submission guidelines.
Please be sure your video(s) comply with the following instructions:
1. Video must be an original production, in final edited form with a clear voice-over in English, connecting the narration with images shown. The video should not exceed 7 minutes, and background music is not accepted.
2. Display the video title, name of the surgeon(s) and co-authors, an institution where the surgery was performed, and the location (city, state/country) at the beginning.
3. Any conflicts of interest are to be shown on a disclosure slide following the title slide.
4. Videos submitted with identifiable patient information or features will be rejected. Please obscure the patient’s name on any images, remove personal information and blur the patient’s face if it is not part of the procedure.
5. If the information is about a clinical case, the narration must provide information about the subject, such as medical history, diagnostic workup and outcome. If the information is about a particular procedure, the video must address the components of the procedure and include information that addresses the various surgical techniques.
6. Do not use copyrighted images, illustrations or videos unless you are the copyright holder.
7. Ensure that text graphics are legible when the video is rendered to its final format.
8. External views of laparoscopy should be recorded with a video camera if possible and not with the laparoscope. When recording laparoscopy, use smoke evacuation to optimize image clarity using energy devices. Be sure to record laparoscopic videos in the highest quality possible.
Video Abstract Requirements
The abstract requires a 300-word summary of the video content, 5 keywords related to your video and must highlight one educational or technical aspect addressed by the video. It would be best if you also chose the category most accurately reflects your video topic from the above table named abstract categories.
Presenting Author
Only authors listed in the author string can present at the time of submission. If one of the listed co-authors cannot present the study, the Organizing Committee will have to withdraw the video from the program.
IASGO stands for the International Association of Surgeons, Gastroenterologists, and Oncologists that was founded in 1988 and today, has more than 1700 members from over 90 countries worldwide.
The mission of this organization is the globalization of medical knowledge and expertise through a well-structured system of continued medical education. IASGO believes that medical knowledge and expertise belong to every human being and that it has to be available beyond any discrimination, based on individual, institutional, or national level, to every patient that strives for survival because of challenging and life-threatening diseases.
We are currently experiencing an era of transition with significant innovations. Exciting scientific and technological advances are changing all areas of our lives. The recent emergency linked to the pandemic from COVID-19 has inevitably played the role of an accelerator by increasing society’s focus on health issues. As a result, new technologies and medical therapies are emerging for many diseases.
At the IASGO 2023, we will discuss recent developments in surgical oncology to improve patient care and quality standards. Molecular biology and biotechnology are also revolutionizing medicine. The management of cancers is changing through the characterization of tumor molecular biological profiles using next-generation sequencing. The future of medicine is increasingly taking shape with the latest discoveries in genetics that enable promising new directions in oncological therapies.
Understanding the specific disease in each cancer patient evoked a paradigm shift in oncology and is now opening new horizons in diagnostics and therapeutics. Progress is being made in the development of molecularly targeted therapy. Precision medicine aims to design and optimize the pathway for early diagnosis, assess prognosis, and tailor therapeutic interventions. Furthermore, artificial intelligence algorithms can now successfully predict the risk of cancers and gastrointestinal diseases.
More and more evidence suggests that lifestyle plays a fundamental role in well-being and patients’ health. Normal body weight and constant physical activity prevent gastrointestinal, metabolic, and neoplastic diseases and manage their presence. Likewise, proper nutrition counteracts chemotherapy’s side effects and helps faster recovery after surgery as demonstrated in the gudilenes of the ERAS Socieity with which IASGO cooperates.
The newly established IASGO multidisciplinary clinical trials consortium for the treatment of oncological diseases seeks to improve diagnossis and increase treatment feasibility and efficacy. It also aims to make the available treatments more accessible, improves patients’ quality of life and compliance with therapies and follow-up, and thus optimize the use of resources.
Last but not least, sustainability is becoming increasingly important in medicine and healthcare. Physicians need to be aware of eco-friendly solutions that provide high-quality care to patients while lowering costs and reducing environmental impact. Prevention, telemedicine counseling, training, and expanding healthcare coverage equitably should be the way forward.
For all these reasons and more, please join us at the upcoming IASGO Congress held at the Palazzo Della Gran Guardia in Verona between 9-12 September 2023. Verona is a spectacular city, a key part of Italian history, a symbol of art and culture in the world, and a recognized UNESCO heritage. We look forward to seeing you at this celebration of the latest medical and scientific advancements in GI cancer treatment during the IASGO 34th World Congress in the beautiful and traditional city of Verona.
注册费:
Attandee |
EARLY Fee
(Until July 16th, 2023) |
Late Fee
(July 17th – August 25th, 2023) |
Onsite fee
(August 26th, 2023 – onsite) |
Congress Registration
(IASGO Members) |
350.00 € |
450.00 € |
500.00 € |
Congress Registration
(NON-IASGO Members) |
650.00 € |
850.00 € |
1100.00 € |
Pharmacist/Nurse/ Young Scientist Under 35** |
250.00 € |
350.00 € |
450.00 € |
Emerging countries*** |
300,00 € |
400,00 € |
500,00 € |
Company badge |
500.00 € |
600.00 € |
700.00 € |
Pre-course Registration ****
IOUS and ablations in liver tumors |
122,00 € |
122,00 € |
122,00 € |
Pre-course Registration ***** Advances in gallbladder and common bile duct stones management |
122,00 € |
122,00 € |
122,00 € |
Gala Dinner – Sept 11th |
122,00 € |
122,00 € |
122,00 € |
Fees are inclusive of current VAT (22%) and are quoted in Euro. |
* Membership fee is applied only to IASGO Members in good standing with membership fee.
IASGO membership renewal price is 200€
– IASGO first time membership price is 100€
For membership renewal or first timers only visit IASGO official Membership page: https://iasgo.net/index.html#Membership
** Pharmacist/Nurse: Proof of status is required to finalize the registration. Young Scientist Under 35: A letter from a specialization school is required.
*** Emerging Countries are those state as “low-income” and “lower-middle income” as per World Bank country classifications. For a complete list of these countries, please check the World Bank website here.
**** Pre-course “IOUS and ablations in liver tumors” – Limited availability – REGISTER NOW!
It will be held at Policlinico Universitario G.B. Rossi – Borgo Roma Piazzale L.A. Scuro, 10 – 37134 Verona
***** Pre-course “Advances in gallbladder and common bile duct stones managemen” – Limited availability – REGISTER NOW!
It will be held at Policlinico Universitario G.B. Rossi – Borgo Roma Piazzale L.A. Scuro, 10 – 37134 Verona
IASGO Verona 2023 Delegates registration fee includes:
-
Admission to all Congress sessions, Poster and Exhibition areas.
-
Admission to the Welcome Ceremony
-
Congress Programme
-
Certificate of Attendance (to be received via e-mail after the event)
Proof of Status for Young Scientist
Kindly find here below the mandatory requirements that a valid Proof of Status needs to meet:
-
It must be issued in English;
-
It must be issued on official hospital or university letterhead;
-
The date of issue has to be not older than 6 months starting from the registration date;
-
It must display the applicant’s full name and date of birth;
-
It has to be signed by the head of department (hospital or academic institution) confirming the full-time status of the applicant;
-
It has to include the following head of department’s details: full name, department, email address and telephone number;
Please, also take into consideration the following:
-
Invalid Proof of Status cannot be accepted: the IASGO Verona 2023 decision will be final and the registration fee will be automatically updated to the Non-Member full fee;
-
Once the online pre-registrations period for the Congress is closed, participants still wishing to register will need to bring their Proof of Status on-site, in order to benefit from the reduced fee.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|